Search Result "OPC67683"
Tackling Drug-Resistant Tuberculosis: Current Trends and Approaches
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 17 Issue: 6 Year: 2017 Page: 549-570
Author(s): Rashmi Tandon,Mahendra Nath
New Anti-Tuberculosis Drugs in Clinical Development: An Overview
Journal: Current Bioactive Compounds
Volume: 5 Issue: 2 Year: 2009 Page: 137-154
Author(s): Jerome Guillemont, Frederic Lieby-Muller, Nacer Lounis, Wendy Balemans, Anil Koul, Koen Andries
Filling the Pipeline - New Drugs for an Old Disease
Journal: Current Topics in Medicinal Chemistry
Volume: 14 Issue: 1 Year: 2014 Page: 110-129
Author(s): Matthias Stehr,Ayssar A. Elamin,Mahavir Singh
Oxazolidinones as Anti-tubercular Agents: Discovery, Development and Future Perspectives
Journal: Current Medicinal Chemistry
Volume: 22 Issue: 38 Year: 2015 Page: 4379-4397
Author(s): Pradeep S. Jadhavar,Maulikkumar D. Vaja,Tejas M. Dhameliya,Asit K. Chakraborti
Molecular Players in Tuberculosis Drug Development: Another Break in the Cell Wall
Journal: Current Medicinal Chemistry
Volume: 24 Issue: 36 Year: 2017 Page: 3954-3969
Author(s): Flavia Squeglia,Maria Romano,Alessia Ruggiero,Rita Berisio
DprE1 - from the Discovery to the Promising Tuberculosis Drug Target
Journal: Current Pharmaceutical Design
Volume: 20 Issue: 2 Year: 2014 Page: 4379-4403
Author(s): Katarina Miku sova, Vadim Makarov, Joao Neres
Lessons from Seven Decades of Antituberculosis Drug Discovery
Journal: Current Topics in Medicinal Chemistry
Volume: 11 Issue: 1 Year: 2011 Page: 1216-1225
Author(s): Clifton E. Barry
Management of Adult Active Tuberculosis Disease in Era of HIV Pandemic, Current Practices and Future Perspectives
Journal: Infectious Disorders - Drug Targets
Volume: 11 Issue: 2 Year: 2011 Page: 134-143
Author(s): Jean B. Nachega, Bernd Rosenkranz, Gary Simon, Richard E. Chaisson, Andreas H. Diacon, Jantjie Taljaard
Programs to Facilitate Tuberculosis Drug Discovery: The Tuberculosis Antimicrobial Acquisition and Coordinating Facility
Journal: Infectious Disorders - Drug Targets
Volume: 7 Issue: 2 Year: 2007 Page: 92-104
Author(s): R. C. Goldman, B.E. Laughon, R. C. Reynolds, J. A. Secrist, J. A. Maddry, M.-A. Guie, A. C.Poffenberger, C. A. Kwong, S. Ananthan
Isoniazid Derivatives as Anti-Tubercular Agents: From Structural Designto Clinical Investigations
Journal: Infectious Disorders - Drug Targets
Volume: 23 Issue: 3 Year: 2023 Page: 44-68
Author(s):